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A rd~icuiacytc tramtltiticrn xyslcm was dcplercd uf’Bunctionzt\ Et”.? by lre~lmknt wirh diphthcriu toxin CDT) Ilagnrenl A und MAD. After diillyKiJ 
10 rrmovc NAD, the xyrtcm wd$ rreantritutcd using pnparrtrkns dFS2 dcrivcd l’ram pytii*lK calls. blnlrealdd rr~d reconxtiru~ed lysrrrx prmitrcd 
aimilxr r.rrer, af’trsmdnriun. AS exparcd, when Rt+re#ilcd EF.2 was used ta rccrmrtilw the ayxtrm. no rnnrlrrtion occurred. turthcrmurr LFGX 
rcrctin~ with lhe cnduycnoux ADP=ribwryl lrttndkr#sc f’ram pyBk1K eoh ~8% aidu rlnirbk IO reXWe prt%eh~ rynthcaix in tlrc recOnrli~Wd wyxlCn1. 
Tbz stud& augyext that cukarkatis cellular AUP~riba~yl tr#nxGzrttsed may play a role in repdnriny prcriicn xymhcs;in. 
ADP-riberyl transl”eruxr; EFa2; Protein $ynrhc&ix: Diphtheria toxin; PyklHK eelI 
1. INTROBUCX-ION ribatiumss, and adsorbed with charcoal (Norit S6) to remove en- 
dsgenuur NAD, and a hiatsmlne~cantrinintj buffer WZIS used [6], 
Diphrheria toxin (BT) and Psettdortmrm cxoroxin 2.7. M~d~kvztiun of EF-2 
kill eelIs by catalyzing the specific ADP-ribosylation of Aliquors o( EF-2 were madilicd by addition of either cndoyenous 
eukaryocic elongation factor 2 (EF-2) ac a modified ADP-riboayl tranrfcrase or 0,05 II& of DT rrapmcnt A IO O,l ml rcnc. 
hi&dine residue, termed diphthamidc [ 11, thereby lion volume (containing 25 mM fris+iCI (pli 8.0), I Ml 
functionally inactivating the molecule and inhibiting 
dirhiothreitol and loQpp EF.2 L NAD or [“C-orJenosinc]~NAD) and 
protein synthesis. Cellular mono (ADP-ribosyl) 
were irtcubared RI 22% until maximum transfer of radiolabel to a 
TCA-prccipitable form had occurred. Reaction mixtures were then 
transferases with similar activity have been i’solaced dialyrcd extensively against baffcr A [7) a~ O*C. 
from various sources including polyoma virus 
transformed baby hamster kidney (pyBHK) cells [2,3], 
2.3 a In vitro trarrslalion systen 
turkey erythrocytes [4] and bovine liver [5]. In this 
Rabbit reticulocytc IysatCs wcrcprcpared as described [8]. Aliquots 
were [rcatcd with 37 &ml D’I’ fragment A [P] and SO&ml NAD 
report we show that preparations of EF-2 from pyF3HK at 20BC for 15 min ;o inactivate cndogcnous EF.2. Portions of this 
cells, which arc modified either by diphtheria toxin or inactivated lysate wcrc then dialyrcd extensively against de-ion&d 
by the endogenous ADP-ribosyl transferase, are no water at O°C to rcmovc NAD, and dialyzed lysa~es were reconstituted 
longer functional in an in vitro translation system. 
by addition of EF-2 (see above). Translation reaction mixlure was ah- 
These results suggest that cellular ADP-ribosyl 
quoted from a stock composed of 800 gl lysatc, 10 pl of 10 mE/mI 
creatinc phosphokinasc, 50 ~41 of 0.3 M crcatinc phosphate in 10 mM 
transferase may play a role in regulating translation. Tris.HC1 (pH 7,5), 50 141 of 2 M KCI, 100 ~1 of the 19 es’scntial amino 
acids at 0.5 mM each, 6141 of 4 mM hcmin, 10 jrl of 400 mM M&l 
and 6~1 of 200 mM dithiothrcitol. EF-2, ADP-ribosylatcd EF.2 or 
2. MATERIALS AND METHODS NAD were added as needed, and reactions were incubated at 30°C 
for 3 min, chilled to 0°C and then completed by addition of 5 /tl of 
2, I 4 Preporation und quantitbrion of EF-2 [lH]teucinc (56,s Ci/mmol; NEN), prior to incubati&i at ‘30°C. In- 
EF-2 was isolated from pyBHK cells as described [2,3] and quan- corporation of radiolabel into protein was measured byliquid scin- 
titated by the procedure of Gill and Dinius [a], Briefly, 10 lrl of EF-2 tillation counting of TCA-prccipitable material. 
was reacted with 0.05 ~6 of DT fragment A for 20 min at 22OC in 
0,l ml (containing 6.33 pM [U-‘JC-adenosine]-NAD 
(55.4 mCi/mmol; NEN), 1 mM,dithiothreito! and 25 mM Tris-WC1 
(pH 8.0)). Trichloroacetic acid (TCA)-precipitable radioactivity was 
3. RESULT’S 
collected on Millipore filters and counted by liquid scintillation. EF-2 Reticulocyte lysates were determined to contain 
content of reticulocyte lysates was determined similarly, except 
lysates were pretreated with 0.5 M NaCl to free EF-2 from 
90 pg/ml endogcnous BF-2, which was reduced to an 
effective concentration of 2,7 fig/ml after treatment 
with DT fragment A and NAD. Following dialysis, the 
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PyW#% ES2 was mcadifiad In vitro by rhr en- 
dergenoua ADP ribasyl rransferas;o or by DT fragment 
A in rhc presence ST [‘dC-arlrtinaxlrr~]-NA%J, “Phi% en- 
abled us to determine the rcaerian kinetics for Fhf fwa 
enzymca nd thereby to ascertain the incubarion rime 
required for eomplere ~~~jf~~a~i~~ of EF-2. Ths ability 
sf ADP-~iborylrrcd EF-2 to reconstitute the! fragment 
A-treated, translation aya~em was then cxamincd. As ex- 
pected, ADP~ribosylartion f Ef$ by DT frr@lmont A
abolished its ability to rcctinatitutc: the cell-fret protein 
synthesis ystem, In addition, %F=2 modified by the en- 
dogcnous ADP=ribesyl transferase was also inactive in 
the in vitro system, whereas mock-rr&Wxl F-2 (re- 
acting with cranaferasc in the trboenee of NAD) retained 
its fwetianality (Fig, 2). 
IO 
tlilN!tOS 
4. DISCUSSlON 
Fig. I. Reccm~litu~l~n nf the rcticrrlocyle lranslntian ryuem with 
indicwd imoim~5 0r cxogcnuul pyBHK-derived EF-2 (lyaatfs were 
dcplclcd 0r cncl0gcnouw W-2; reaction volun~c = 0.1 ml; .9x section 
2). Data are averages from 81 lcnrt two rxperinienls. 
EF-2, while addition of increasing amounts of pyBHK 
EF-2 results in progressive augmentation of protein 
synthesis (Fig, 1). At an exogenous EF-2 concentration 
of 68 /g/ml the rate of protein synthesis in the 
reconstituted system is equivalent o that of the un- 
treated reticulocyte lysate (data not shown), 
We have previously identified an endogenous ADP- 
ribosyl cmnsferase in mammalian cells which is able Co 
modify the same diphthamide residue of EF-2 Chat is 
affected by bacterial proteins such as Pseudorrtonas cx- 
ocoxin and diphtheria toxin [2,3]. WC now provide 
evidence that the cellular enzyme not only ADP- 
ribosylatcs EF-2, but that it also leads to functional in- 
activation of the molecule, thereby inhibiting protein 
synthesis. 
There is strong biochemical evidence to suggest hat 
the EF-2 molecule itself contains an ADP-ribosyl 
transferase activity, which can be activated during 
purification of the protein in vitro, We believe that this 
is probably due to conformational changes in the pro- 
tein, since we expect ADP-ribosyl transferase activity 
EF-2 
V-2 x mock 
to be under stringent control in viva, Interestingly, 
there is significant similarity between the enzymic do- 
mains of the bacterial toxins [lO,l l] and mammalian 
EF-2 (Fig. 3). We are currently investigating the 
possibility that carboxy terminal subfragments of EF-2 
may contain an active enzymic site. The data presented 
suggest that auto-ADP-ribosylation of EF-2 may repre- 
sent an important control mechanism in eukaryotic 
cells, perhaps regulating peptide chain elongation (e.g. 
._ during the translocation of proteins across the en- 
g doplasmic reticulum [12]). 
S 
EF-2xDT Finally, the potential toxicity of an endogenous 
EF-Prc ADPR 
no EC-2 ADP-ribosyl transfemse could be exploited in anti: tumor or anti-viral drugs. Pseudomonas exotoxin (PE), 
for example, has been fused to the cellular ligand CD4, 
to produce a hybrid PE-CD4 protein which possesses 
0 10 20 50 potent cytotoxicity for HIV-infected cells [ 131. 
Minutea However, PE-CD4 is highly immunogenic and an- 
tibodiis a&Grist he protein are likely to interfere with 
Fig. 2. Reconstitution of the reticulocyte translation system by 
addition of exoger~ous W-2 (5s &ml), either untreated (EF-2), 
its efficacy in vivo [ 141. In contrast, a hybrid toxin bas- 
mock-treated W-2 x mock) or modified using diphtheria toxin 
ed on the cellular enzyme would be expected to be far 
(EF-2 X DT) or the pyBWK-derived cellular ADP-ribosyl transferase less immunogenic and thus considerably more ef- 
(EF-2 x ADPR). Data are averages from at least two experiments. festive. 
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EF-2 629 KQRABYLM~YGMVAEARnIWCFG~~G~G~NXLTDITKQV~YtElr,IK,. ,a,. ,.DS 6?@ 
1IiaI II III I.1 
PE 463 D .“,a ..;IICRGlr~AGDPAMYGYAQDQEPDARG~~~~ALL~~~.. ,.....R; SO6 
I *I*** III II*I’l* I* It’llll~ ’ 
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_I__“_ 
i 
EF-2 679 WAGFQWATKEGALCEE.NMRG, .~DVH..DVTLHADAIHRGGGQILPTARRC 726 
II_’ I *I I el .a 
PE 507 SLPGFYRTSLTL&A. AGEV, , ERLIG;I , a PLFLRLDA . . . . . 1 , . 3 . ..(I. 541 
I II 111*1*1 1-1 II* * I* I I ‘I 
DT DNAETIKKELGLSLTEPLMEQVGTEEFIKRFGDGASRWL. .,. . . r, 1. 8.1 r. 
EF- 2 72 9 LYASVLTAQPRLMEP IYLVEIQCFEQWGGIYGVLNRKRGHVFEESQVAG 7 7 8 
**I ‘I I. I 1’1 
PE 542 .,........,...,.....;TGPEEEGGRISTILCW... . , . . , .PLAE 562 
l*lllII~ ’ :* , * 
DT ,.,....*.,I......*,. SLPFAEGSSSVEXINN’U., . z r.. . ,E.;)E; 
a 
EF-2 779 TPMF’JVKAYLPVNESFGFTADLRSNTGGQAFPQCVFDHWQILPGDPFDNS 828 
II l ‘.I ’ II l 
PE 563 RTWIPSA........ a :,T~,~.~GGDLDPSSIPDKE;~A~S~L~.;)YA 601 
III1 I . II* I *I 
DT KALSVELE,. . . . . . I. INFETR,GKRGQDaMYEYMAQACAGNRVRR 
iS (10) 50% ID; 20% CONS 40% ID; 30% CONS 
;p (12) 25% ID; 42% CONS 50% ID; 17% CONS 
(28) 36% ID; 29% CONS 11% ID; 39% CONS 
III (13) 
*,. 
31% ID; 34% CONS 23% ID; 31% CONS 
Fig. 3. Amino-acid similarity between the enzymic domains of Pseudotnonas exotoxin (PE) and diphtheria toxin (D’f), and the carboxyi terminal 
half of human EF-2, showing identical (+ , ID) and conservatively substituted residues ( i , CONS). Experimentally identified active site residues 
in PE and DT are indicated in bold [lo,1 1); regions (i)-(iii) were identified by Collier [IO]. Sequence analysis was performed with GCG Software 
[IS], using the algorithm of Needleman and Wunsch [16]. 
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